Aptevo Therapeutics Inc.
APVO | NASDAQ
$1.84
$0 (0.00%)
At close: Sep 21, 2026, 3:59 PM ET
$1.88
+$0.04 (+2.28%)
Pre-market:
Sep 22, 2026, 4:14 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 9.8M | 14.53M | 21.62M | 21.06M | 9.41M | 2.14M | 8.71M | 7.75M | 8.07M | 10.25M | 16.9M | 19.11M | 21.01M | 25.33M | 22.64M | 22.15M | 29.43M | 34.99M | 45.04M | 52.12M | 60.39M | 57.52M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 68K | 68K | 746K | 746K | 746K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M | n/a | n/a | 3.11M | 3.66M | 3.1M | 3.11M | 2.42M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1M | 851K | 853K | 77K | 82K | 120K | 256K | 624K | 715K | 691K | 689K | 649K | 764K | 1.58M | 744K | 1.09M | 1.31M | 2.14M | 2.04M | 1.27M | 1.33M | 1.34M |
Total Current Assets | 10.8M | 15.98M | 23.08M | 22.65M | 11.08M | 3.61M | 10.66M | 10.01M | 9.58M | 12.07M | 19.07M | 21.13M | 22.68M | 28.49M | 27.45M | 24.62M | 31.4M | 41.67M | 52.57M | 58.87M | 65.77M | 62.85M |
Property-Plant & Equipment | 3.72M | 3.92M | 4.11M | 4.35M | 4.54M | 4.74M | 4.93M | 5.13M | 5.34M | 5.56M | 5.78M | 6M | 6.23M | 6.48M | 6.77M | 7.08M | 7.4M | 3.44M | 3.96M | 4.39M | 4.96M | 5.16M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.72M | 3.92M | 4.11M | 4.35M | 4.54M | 4.74M | 4.93M | 5.13M | 5.34M | 5.56M | 5.78M | 6M | 6.23M | 6.48M | 6.77M | 7.08M | 7.4M | 3.51M | 4.03M | 5.13M | 5.71M | 5.9M |
Total Assets | 14.52M | 19.9M | 27.19M | 27M | 15.62M | 8.34M | 15.59M | 15.15M | 14.92M | 17.63M | 24.84M | 27.13M | 28.91M | 34.97M | 34.22M | 31.7M | 38.8M | 45.18M | 56.6M | 64.01M | 71.47M | 68.75M |
Account Payables | 1.16M | 890K | 877K | 2.22M | 2.9M | 3.79M | 3.05M | 3.53M | 3.74M | 3.72M | 3.98M | 4M | n/a | n/a | n/a | 3.24M | 3.27M | 3.91M | n/a | n/a | n/a | 5.35M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 919K | 892K | 866K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2M | 2M | 2M | 2M | 11.67M | 11.17M | 10.67M | 10.17M |
Other Current Liabilities | 4.27M | 2.98M | 4.31M | 1.49M | 1.99M | 1.6M | 3.15M | 1.43M | 791K | 968K | 1.14M | 1.31M | 6.91M | 5.8M | 6.71M | 2.54M | 1.73M | 17.95M | 23.09M | 21.21M | 20.2M | 13.83M |
Total Current Liabilities | 5.19M | 4.76M | 6.05M | 5.61M | 4.89M | 5.39M | 6.21M | 5.88M | 5.42M | 6.3M | 7.22M | 6.84M | 6.91M | 5.8M | 8.71M | 7.79M | 7M | 23.86M | 34.76M | 32.38M | 30.86M | 29.34M |
Long-Term Debt | 3.29M | 3.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.46M | 1.91M | 2.36M | 2.8M | 3.71M | 4.01M | 4.32M | 4.61M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14K | 14K | 14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23.34M | 15.58M | 18.71M | 20.54M | 22.17M |
Total Long-Term Liabilities | 3.29M | 3.53M | 3.76M | 3.99M | 4.21M | 4.42M | 4.63M | 4.84M | 5.04M | 5.23M | 5.4M | 5.58M | 5.75M | 5.92M | 7.54M | 8.15M | 8.75M | 27.21M | 20.63M | 24.33M | 26.73M | 28.91M |
Total Liabilities | 8.48M | 8.29M | 9.81M | 9.6M | 9.1M | 9.82M | 10.84M | 10.73M | 10.46M | 11.53M | 12.62M | 12.41M | 12.66M | 11.71M | 16.24M | 15.93M | 15.75M | 51.07M | 55.39M | 56.71M | 57.59M | 58.25M |
Total Debt | 4.21M | 4.42M | 4.63M | 3.99M | 4.21M | 4.42M | 4.63M | 4.83M | 5.03M | 5.21M | 5.4M | 5.58M | 5.75M | 5.92M | 9.54M | 10.15M | 10.75M | 5.87M | 16.72M | 16.79M | 16.86M | 16.9M |
Book Value | 6.04M | 11.61M | 17.38M | 17.39M | 6.52M | -1.47M | 4.76M | 4.42M | 4.46M | 6.1M | 12.22M | 14.72M | 16.25M | 23.26M | 17.97M | 15.76M | 23.05M | -5.88M | 1.22M | 7.29M | 13.88M | 10.5M |
Book Value Per Share | 5.05 | 10.95 | 17.42 | 77.32 | 159.09 | -363.61 | 1.17K | 5.58K | 16.89K | 118.37K | 367.91K | 685.74K | 1.47M | 1.94M | 1.63M | 1.81M | 2.69M | -698.44K | 145.5K | 873.63K | 1.79M | 1.39M |
Common Stock | 114K | 114K | 114K | 110K | 99K | 84K | 84K | 82K | 69K | 66K | 61K | 56K | 49K | 49K | 48K | 47K | 47K | 47K | 47K | 47K | 47K | 46K |
Retained Earnings | -288.26M | -281.91M | -275.12M | -269.22M | -260.19M | -253.99M | -247.58M | -241.27M | -236.16M | -230.28M | -223.45M | -217.55M | -211.21M | -203.26M | -206.04M | -201.39M | -193.75M | -221.76M | -214.06M | -207.79M | -200.79M | -192.86M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 6.04M | 11.61M | 17.38M | 17.39M | 6.52M | -1.47M | 4.76M | 4.42M | 4.46M | 6.1M | 12.22M | 14.72M | 16.25M | 23.26M | 17.97M | 15.76M | 23.05M | -5.88M | 1.22M | 7.29M | 13.88M | 10.5M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove APVO